{"id":"W2070820990","doi":"10.1056/nejmc1311039","title":"Safety Profile of Extended-Release Niacin in the AIM-HIGH Trial","year":2014,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Niacin; Medicine; Discontinuation; Adverse effect; Statin; Triglyceride; Clinical trial; Internal medicine; Drug; Metabolic syndrome; Cholesterol; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006691513,0.0003594069,0.002205394,0.0004532023,0.00004429321,0.000007877176,0.0003953419,0.000518983,0.0004636347],"category_scores_gemma":[0.001173411,0.0001756224,0.0005287012,0.0003231322,0.0001699033,0.00004838363,0.00002451566,0.003626566,0.000006777995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000110024,"about_ca_system_score_gemma":0.0009476996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00092419,"about_ca_topic_score_gemma":0.00002954639,"domain_scores_codex":[0.994321,0.0009726579,0.001733833,0.0002535816,0.00231653,0.000402409],"domain_scores_gemma":[0.9969392,0.0005381688,0.001143278,0.0008036693,0.0003391165,0.0002365061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02086091,0.0001189811,0.00006052952,0.0007251467,0.0004109235,0.002969289,0.0006158911,0.000005476495,0.00003689877,0.00004366071,0.8356737,0.1384785],"study_design_scores_gemma":[0.2679918,0.005506549,0.0009299137,0.001974589,0.0008731105,0.003490897,0.00008445038,0.000006064379,0.00002476564,0.0002755944,0.7187166,0.0001255746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.02077909,0.005918359,0.0008609079,0.9648126,0.002445478,0.001845285,0.00001572439,0.00001133021,0.003311282],"genre_scores_gemma":[0.1877449,0.003451513,0.0006943146,0.5483397,0.257202,0.00002455311,0.000228051,0.0001305205,0.00218447],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.4164728,"threshold_uncertainty_score":0.9986721,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01869848979158145,"score_gpt":0.2739852988622542,"score_spread":0.2552868090706727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}